AlphaFold predicted structure
CPT1A · P50416

Mean pLDDT
92.4/ 100
Very high
773 residues
Confidence breakdown
- Very high(≥ 90)80%
- Confident(70–90)15%
- Low(50–70)2%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
carnitine palmitoyltransferase 1A
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Hyperammonaemia
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Mitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalcarnitine palmitoyl transferase 1A deficiency
hereditary disease
hypertensive disorder
response to xenobiotic stimulus
cataract
aortic stenosis
heart valve prosthesis
type 2 diabetes mellitus
breast cancer
neoplasm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Carnitine O-palmitoyltransferase 1, liver isoform
Catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion (PubMed:11350182, PubMed:14517221, PubMed:16651524, PubMed:9691089). Also possesses a lysine succinyltransferase activity that can regulate enzymatic activity of substrate proteins such as ENO1 and metabolism independent of its classical carnitine O-palmitoyltransferase activity (PubMed:29425493). Plays an important role in hepatic triglyceride metabolism (By similarity). Also plays a role in inducible regulatory T-cell (iTreg) differentiation once activated by butyryl-CoA that antagonizes malonyl-CoA-mediated CPT1A repression (By similarity). Sustains the IFN-I response by recruiting ZDHCC4 to palmitoylate MAVS at the mitochondria leading to MAVS stabilization and activation (PubMed:38016475). Promotes ROS-induced oxidative stress in liver injury via modulation of NFE2L2 and NLRP3-mediated signaling pathways (By similarity)
CPT1A · P50416

Mean pLDDT
92.4/ 100
Very high
773 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0